Literature DB >> 7713938

The action of interleukin-2 receptor subunits defines a new type of signaling mechanism for hematopoietin receptors in hepatic cells and fibroblasts.

K K Morella1, C F Lai, S Kumaki, N Kumaki, Y Wang, E M Bluman, B A Witthuhn, J N Ihle, J Giri, D P Gearing.   

Abstract

The gene regulatory functions of the human IL-2 receptor (IL-2R) were reconstituted in transiently transfected hepatoma cells. The combination of IL-2R beta and -gamma mediated a strong stimulation via the cytokine response element of the alpha 1-acid glycoprotein gene and the hematopoietin receptor response element, but none via the IL-6 response element or the sis-inducible element. IL-2R alpha enhanced 10-fold the sensitivity of the IL-2R beta.gamma complex to respond to IL-2 or IL-15, but did not modify the specificity or the magnitude of maximal gene regulation. A homodimerizing chimeric receptor G-CSFR-IL-2R beta could mimic the IL-2R action. The IL-2R-mediated gene regulation was similar to that seen with receptors for IL-4 and IL-7, but differed from that for IL-6 type cytokines, thrombopoietin, erythropoietin, and growth hormone. The activation of STAT proteins by the IL-2R was assessed in transfected L-cells and COS-1 cells. Although IL-2R subunits were highly expressed in these cells, no STAT protein activation was detectable. Transient overexpression of JAK3 was unable to change the signaling specificity of the hematopoietin receptors in rat hepatoma, L-, and COS cells, but established a prominent activation of the IL-6 response elements by the IL-2R and IL-4R in HepG2 cells. The data support the model that the IL-2R and related hematopoietin receptors produce at least two separate signals which control gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713938     DOI: 10.1074/jbc.270.14.8298

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Constitutive and impaired signaling of leptin receptors containing the Gln --> Pro extracellular domain fatty mutation.

Authors:  D W White; D W Wang; S C Chua; J P Morgenstern; R L Leibel; H Baumann; L A Tartaglia
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

2.  A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.

Authors:  S Kumaki; H D Ochs; K K Kuropatwinski; T Konno; M S Timour; D Cosman; H Baumann
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.

Authors:  H Kim; T S Hawley; R G Hawley; H Baumann
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

4.  The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors.

Authors:  H Baumann; K K Morella; D W White; M Dembski; P S Bailon; H Kim; C F Lai; L A Tartaglia
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  A potential role for interleukin-15 in the regulation of human natural killer cell survival.

Authors:  W E Carson; T A Fehniger; S Haldar; K Eckhert; M J Lindemann; C F Lai; C M Croce; H Baumann; M A Caligiuri
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

6.  Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.

Authors:  Meir Wetzler; Michael T Brady; Erin Tracy; Zhang-Rong Li; Kathleen A Donohue; Kieran L O'Loughlin; Yijun Cheng; Amir Mortazavi; Amy A McDonald; Padmaja Kunapuli; Paul K Wallace; Maria R Baer; John K Cowell; Heinz Baumann
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

7.  The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells.

Authors:  R Eckenberg; T Rose; J L Moreau; R Weil; F Gesbert; S Dubois; D Tello; M Bossus; H Gras; A Tartar; J Bertoglio; S Chouaïb; M Goldberg; Y Jacques; P M Alzari; J Thèze
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.